Evidence map›Paper›PMID 34215144›Full record

Trial reportNeuroImage. Clinical2021

A functional magnetic resonance imaging investigation of prefrontal cortex deep transcranial magnetic stimulation efficacy in adults with attention deficit/hyperactive disorder: A double blind, randomized clinical trial.

Maya Bleich-Cohen, Guy Gurevitch, Noa Carmi, Mordekhay Medvedovsky, Noa Bregman, Naomi Nevler, Karin Elman, Amit Ginou, Abraham Zangen, Elissa L Ash

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in NeuroImage. Clinical, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Reinventing amlodipine.The Journal of pharmacology and experimental therapeutics · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Observational
  13. Transcranial photobiomodulation for neurodevelopmental disorders: a narrative review.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Maya Bleich-CohenSagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel; Brainsway Ltd, Jerusalem 9777518, Israel. Electronic address: maya44@gmail.com.
Guy GurevitchSagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Noa CarmiSagol Brain Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Mordekhay MedvedovskyDepartment of Neurology, Agnes Ginges Center of Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Noa BregmanSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Naomi NevlerDepartment of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Karin ElmanDepartment of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Amit GinouBrainsway Ltd, Jerusalem 9777518, Israel.
Abraham ZangenBrain Stimulation and Behavior Lab, The Zlotowski Center for Neuroscience, Ben Gurion University, Beer Sheva 8410501, Israel.
Elissa L AshSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Tel Aviv Sourasky Medical Center · ILBen-Gurion University of the Negev · ILHadassah Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ADHD is one of the most prevalent neurocognitive disorders. Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive neuromodulation tool that holds promise in treatment of neurocognitive disorders. Hypoactivity of the prefrontal cortex (PFC) has been observed in ADHD. This study examined the clinical, cognitive, and neural effects of dTMS to the PFC in adults with ADHD by using functional magnetic resonance imaging (fMRI). High frequency repetitive dTMS was applied to either the right or left PFC in 62 adults with ADHD in a randomized, double blind, placebo controlled protocol with 3 study groups: 2 treatment arms (rPFC, or lPFC) and a Sham arm. The study included 15 dTMS/cognitive training treatment sessions. Clinical effects were assessed with the Conners Adult ADHD Rating Scale (CAARS) self-report and the Clinical Global Impression score (CGI) as primary outcome measures. Self-report/observer questionnaires and computerized cognitive testing were also performed to assess clinical and cognitive effects. Neural effects were assessed with fMRI using working-memory (WM) and resting-state paradigms. While the study did not show improvement in the primary endpoints, significant improvements were observed in the CAARS (self-report) inattention/memory sub-scale, as well as increased activations in the rDLPFC, right parietal-cortex and right insula/IFG during WM conditions after treatment in the right stimulation group. Increased rDLPFC activation was associated with larger symptom improvement in the right stimulation group. This study indicates that dTMS is effective in modulating attention related brain networks, and is a feasible technique that may improve attention symptoms in adults with ADHD.

Indexed as

Attention Deficit Disorder with HyperactivityTranscranial Magnetic StimulationAdultBrainDouble-Blind MethodHumansMagnetic Resonance ImagingPrefrontal CortexTreatment OutcomeADHDdTMSfMRIInattentionPFCWorking-memory

Identifiers

PMID34215144
PMCPMC8102620
OpenAlexW3156047526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.